Cleveland HeartLab featured at TEDMED 2012
CLEVELAND-April 05, 2012- Cleveland HeartLab Inc. (CHL), a Glengary client company, today announced that its panel of inflammation biomarkers will be featured at next week's TEDMED 2012 conference in Washington. The annual conference, being held April 10-13, explores the issues, challenges and innovations that are shaping the future of health and medicine.
"Our test panels offer broader prognostic coverage than traditional blood tests, enabling a determination of the degree to which someone is at risk for cardiovascular disease." said Jake Orville, president and chief executive of CHL. The company also said it will launch a new campaign focused on inflammation testing next week.
For the complete story click here.